Faculty

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

HBHL Scientific Director Alan Evans receives Order of Canada

admin — Tue, 08 Jul 2025 17:07:55 +0000

Original article by The Neuro.

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of ��ϲ�� University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

admin — Wed, 06 Aug 2025 15:14:02 +0000

Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Seminar Series Pharmacology & Therapeutics_Jean-Christophe Leroux, Ph.D._"3D printing of drug eluting devices: from tracheal stents to colonic capsules"

admin — Thu, 14 Aug 2025 12:54:30 +0000

Seminar Announcement

Nine ��ϲ��ians appointed to the Order of Canada

admin — Mon, 07 Jul 2025 19:10:48 +0000

Neuroscientist Alan Evans and music performance scholar Michael McMahon among ��ϲ�� community members recognized for exceptional accomplishments and service

Nine members of the ��ϲ�� University community have been appointed to the Order of Canada, one of the country’s highest civilian honours.

Among the honorees are two ��ϲ�� faculty members, Professors Alan Evans (Faculty of Medicine and Health Sciences) and Michael McMahon (Schulich School of Music).

��ϲ�� Cares: Building your team for unplanned life transitions

admin — Tue, 15 Apr 2025 20:12:17 +0000

Join us on May 7th at noon for the next ��ϲ�� Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.

Provost honours 31 ��ϲ�� professors for exceptional research achievements

admin — Thu, 01 May 2025 16:23:55 +0000

��ϲ�� announces 2025 cohort of Distinguished James ��ϲ�� Professors, James ��ϲ�� Professors and William Dawson Scholars
Provost and Vice-President (Academic) Christopher Manfredi has named 31 ��ϲ�� professors as Distinguished James ��ϲ�� Professors, James ��ϲ�� Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

admin — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – ��ϲ�� University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Scaringi Lecture Series in Speech Language Pathology - Research Talk

admin — Mon, 17 Mar 2025 18:53:55 +0000

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 ��ϲ�� College Ave. Room 606